FBTAX
Price
$30.03
Change
+$0.26 (+0.87%)
Updated
Aug 15 closing price
Net Assets
1.4B
LHCIX
Price
$19.35
Change
+$0.12 (+0.62%)
Updated
Aug 15 closing price
Net Assets
7.54M
Interact to see
Advertisement

FBTAX vs LHCIX

Header iconFBTAX vs LHCIX Comparison
Open Charts FBTAX vs LHCIXBanner chart's image
Fidelity Advisor Biotechnology A
Price$30.03
Change+$0.26 (+0.87%)
VolumeN/A
Net Assets1.4B
Lord Abbett Health Care I
Price$19.35
Change+$0.12 (+0.62%)
VolumeN/A
Net Assets7.54M
FBTAX vs LHCIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LHCIX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and LHCIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.4B vs. LHCIX (7.54M). FBTAX pays higher dividends than LHCIX: FBTAX (2.74) vs LHCIX (0.60). FBTAX was incepted earlier than LHCIX: FBTAX (25 years) vs LHCIX (6 years). LHCIX (3.09) is less costly to investors than FBTAX (0.96). LHCIX is a more actively managed with annual turnover of: 88.00 vs. FBTAX (73.00). FBTAX has a lower initial minimum investment than LHCIX: FBTAX (0) vs LHCIX (1000000). FBTAX annual gain was more profitable for investors over the last year : -3.79 vs. LHCIX (-5.28). LHCIX return over 5 years is better than : 5.01 vs. FBTAX (1.58).
FBTAXLHCIXFBTAX / LHCIX
Total Expense Ratio0.960.78123%
Annual Report Gross Expense Ratio0.963.0931%
Fund Existence25 years6 years-
Gain YTD10.364-0.620-1,671%
Front Load6%N/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.4B7.54M18,559%
Annual Yield % from dividends2.740.60455%
Returns for 1 year-3.79-5.2872%
Returns for 3 years22.337.11314%
Returns for 5 years1.585.0132%
Returns for 10 years4.97N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TGTX28.080.31
+1.12%
TG Therapeutics
INMD14.350.07
+0.49%
InMode Ltd
KULR5.25-0.02
-0.38%
KULR Technology Group Inc
MET77.33-0.59
-0.76%
MetLife
GYRO10.00-0.36
-3.52%
Gyrodyne LLC